[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Resilience\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":97},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,41,72],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100599658","efficacy-of-remote-monitoring-in-patients-treated-for-moderate-to-severe-major-depressive-episodes-100599658",false,"NCT07087353","Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes","A Randomized Controlled Trial Assessing the Efficacy of Remote Patient Monitoring in Patients Treated for a Moderate to Severe Major Depressive Episode","EC-102","Inclusion Criteria:\n\n* Adults (≥18 years old) meeting ICD-11 criteria for a moderate to severe major depressive episode\n* Access to a personal smartphone and an internet connection, and cognitively able to use it independently\n\nExclusion Criteria:\n\n* Pregnant women\n* Individuals under legal guardianship or conservatorship\n* Ongoing alcohol or drug abuse considered likely to interfere with study participation, as judged by the investigator\n* Psychiatric or physical comorbidities (e.g., severe neurological or cardiovascular conditions) considered likely to interfere with participation or study results, at the discretion of the Principal Investigator","ALL","18 Years",{"count":20,"type":21},594,"ESTIMATED","INTERVENTIONAL",[24],"NA","Mood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor symptoms in psychiatric patients. The EC-102 randomized controlled trial will evaluate its impact compared to usual care on symptoms, quality of life, healthcare costs, comorbidities, and user adherence and satisfaction.",[27],"Mood Disorder (Depressive Episodes)","RECRUITING","2026-04-27",{"date":31,"type":32},"2026-05-01","ACTUAL",{"date":34,"type":32},"2025-10-31",{"date":36,"type":21},"2027-12-01",{"name":38,"class":39},"Resilience","INDUSTRY",6,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":22,"phases":51,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},"100582776","phase-3-randomized-controlled-trial-of-remote-symptoms-monitoring-with-resilience-pro-compared-to-care-as-usual-only-100582776","NCT06867705","Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only","Digital Monitoring With Patient-Reported Outcomes in Cancer Care: A Randomized Controlled Trial RC - 102 (Resilience Care - 102)","RC-102","Inclusion Criteria:\n\n* Age: Adults ≥ 18 years.\n* Informed Consent: Patient giving signed informed consent to participate in the RC - 102 clinical study.\n* Diagnosis: Patients with cancer at any stage.\n* Systemic Treatment\n* Remote Monitoring Eligibility: Access to a smartphone\n* Language: Ability to understand and communicate in the language(s) in which the trial is conducted.\n\nExclusion Criteria:\n\n* Age: Patients under 18 years of age.\n* Life Expectancy: Patients with a life expectancy of less than 6 months as estimated by the treating physician.\n* Concurrent remote monitoring\n* HSCT or CAR-T Therapy\n* Cognitive Impairment\n* Pregnancy or breastfeeding\n* Subject under administrative or judicial control",{"count":50,"type":21},1458,[52],"PHASE3","The goal of this clinical trial is to learn if Resilience PRO, a digital solution performing remote symptoms monitoring, can improve the quality of life of patients with a diagnosis of cancer receiving systemic anticancer treatment.\n\nThe main question it aims to answer is:\n\n\\- Do patients with a diagnosis of cancer receiving systemic anticancer therapy and using Resilience PRO have an improved quality of life? Researchers will compare patients using Resilience PRO plus care as usual to patients receiving care as usual only.\n\nParticipants in the intervention arm will use Resilience PRO, a mobile phone application regularly asking participants about their symptoms. For clinically important symptoms, an alert is sent to the care team that can incorporate that information to timely adjust the care of the participants. Participants both in the control arm and in the intervention arm will further receive care as usual.",[55],"Cancer",[57,58,59,60,38,61,62],"Remote Patient Monitoring","Remote Symptom Monitoring","Digital medicine","Resilience PRO","PRO","Patient-reported Outcomes","2026-04-02",{"date":65,"type":32},"2026-04-03",{"date":67,"type":32},"2025-04-01",{"date":69,"type":21},"2029-12",{"name":38,"class":39},36,{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":22,"phases":82,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":88,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":4},"100596252","phase-3-randomized-controlled-trial-comparing-remote-patient-monitoring-vs-standard-care-in-ibd-patients-initiating-or-changing-advanced-therapy-100596252","NCT07043036","Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy","Randomized Controlled Trial Comparing a Strategy Based on Continuous Monitoring at Home Using a Digital Remote Patient Monitoring Solution to Reference Standard in Patients With IBD Initiating an Advanced Therapy or Undergoing a Substantial Change in Their Advanced Therapy.","GC-102","Inclusion Criteria:\n\n* Diagnosed with Inflammatory bowel disease, either Crohn's disease or ulcerative colitis, at least 3 months before enrolment\n* Initiating an advanced therapy (i.e., biologic therapy or small molecule) OR occurrence of a substantial change in the treatment of the disease.\n* Active disease.\n\nExclusion Criteria:\n\n* Patients with altered intestinal continuity or function due to major abdominal surgery (e.g., stoma, extensive resection, anastomosis), uncontrolled intra-abdominal abscess, or active perianal disease.\n* Patients for whom digestive surgery is expected during the study period.\n* Patients unable or unwilling to use or already using GutyCare.\n* Vulnerable individuals as defined by French law.",{"count":81,"type":21},116,[52],"This clinical trial aims to evaluate whether GutyCare, a digital remote patient monitoring (RPM) solution, can enhance organizational outcomes while maintaining non-inferior clinical results in patients with inflammatory bowel disease (IBD) who are initiating or undergoing significant modifications in advanced therapy.\n\nThe study compares standard care to an intervention involving the use of GutyCare, a mobile application that collects patient-reported outcomes related to symptoms.\n\nWhen clinically significant symptoms are identified, alerts are transmitted to the care team, facilitating timely and personalized therapeutic adjustments.",[85],"IBD",[57,59,87,38,61,62],"GutyCare","NOT_YET_RECRUITING","2025-06-20",{"date":91,"type":32},"2025-06-29",{"date":93,"type":21},"2025-06",{"date":95,"type":21},"2027-06",{"name":38,"class":39},""]